impaired complement alternative pathway_Cfp<tm2.1Song>/Cfp<tm2.1Song>,Lyz2<tm1(cre)Ifo>/Lyz2<+>

http://metadb.riken.jp/0002472I129129P2OlaHsdC57BL6SJLCfptm21SongCfptm21SongLyz2tm1creIfoLyz2Cfptm21SongLyz2tm1creIfoLyz2

impaired complement alternative pathway_Cfp<tm2.1Song>/Cfp<tm2.1Song>,Lyz2<tm1(cre)Ifo>/Lyz2<+>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• lysozyme 2
  http://metadb.riken.jp/db/mgi_rdf/MGI:96897
• complement factor properdin
  http://metadb.riken.jp/db/mgi_rdf/MGI:97545

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Cfp<tm2.1Song>/Cfp<tm2.1Song>,Lyz2<tm1(cre)Ifo>/Lyz2<+>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Cfp<tm2.1Song>|Lyz2<tm1(cre)Ifo>|Lyz2<+>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129 * 129P2/OlaHsd * C57BL/6 * SJL

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• impaired complement alternative pathway
  http://purl.obolibrary.org/obo/MP_0002472

文献

http://purl.org/net/cito/citesAsAuthority

• Yuko. Kimura, et.al., Genetic and therapeutic targeting of properdin in mice prevents complement-mediated tissue injury., The Journal of clinical investigation, 2010, 120
  http://rdf.ncbi.nlm.nih.gov/pubmed/20941861